We’re currently experiencing technical issues with the PHS website. Our team is investigating and working to restore normal service. Thank you for your patience.

Abstract

Almost 18 months following its first report, coronavirus disease 2019 or COVID-19 continues to cause fatalities worldwide and disrupt all aspects of daily life. Our knowledge of this condition, the mechanisms of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and its systemic consequences have improved through an unprecedented global effort from the diagnostic, medical, and public health research community. As a consequence, effective treatments and vaccines have been developed, tested, and implemented within record timeframes to mitigate some of the critical effects of the COVID-19 illness.

Rights

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite as

Bularga, A., Chapman, A. & Mills, N. 2021, 'Mechanisms of Myocardial Injury in COVID-19', Clinical Chemistry, 67(8), pp. 1044-1046. https://doi.org/10.1093/clinchem/hvab111

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 03 November 2025